258 related articles for article (PubMed ID: 22823200)
1. Myeloperoxidase: a leukocyte-derived protagonist of inflammation and cardiovascular disease.
Nussbaum C; Klinke A; Adam M; Baldus S; Sperandio M
Antioxid Redox Signal; 2013 Feb; 18(6):692-713. PubMed ID: 22823200
[TBL] [Abstract][Full Text] [Related]
2. Myeloperoxidase and cardiovascular disease.
Nicholls SJ; Hazen SL
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1102-11. PubMed ID: 15790935
[TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease.
van der Veen BS; de Winther MP; Heeringa P
Antioxid Redox Signal; 2009 Nov; 11(11):2899-937. PubMed ID: 19622015
[TBL] [Abstract][Full Text] [Related]
4. Myeloperoxidase and Neurological Disorder: A Crosstalk.
Pravalika K; Sarmah D; Kaur H; Wanve M; Saraf J; Kalia K; Borah A; Yavagal DR; Dave KR; Bhattacharya P
ACS Chem Neurosci; 2018 Mar; 9(3):421-430. PubMed ID: 29351721
[TBL] [Abstract][Full Text] [Related]
5. Myeloperoxidase delays neutrophil apoptosis through CD11b/CD18 integrins and prolongs inflammation.
El Kebir D; József L; Pan W; Filep JG
Circ Res; 2008 Aug; 103(4):352-9. PubMed ID: 18617697
[TBL] [Abstract][Full Text] [Related]
6. Role of myeloperoxidase in cardiology.
Ikitimur B; Karadag B
Future Cardiol; 2010 Sep; 6(5):693-702. PubMed ID: 20932115
[TBL] [Abstract][Full Text] [Related]
7. The Role of Myeloperoxidase in Biomolecule Modification, Chronic Inflammation, and Disease.
Davies MJ; Hawkins CL
Antioxid Redox Signal; 2020 May; 32(13):957-981. PubMed ID: 31989833
[No Abstract] [Full Text] [Related]
8. Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function.
Aratani Y
Arch Biochem Biophys; 2018 Feb; 640():47-52. PubMed ID: 29336940
[TBL] [Abstract][Full Text] [Related]
9. Contributions of myeloperoxidase to proinflammatory events: more than an antimicrobial system.
Nauseef WM
Int J Hematol; 2001 Aug; 74(2):125-33. PubMed ID: 11594511
[TBL] [Abstract][Full Text] [Related]
10. Myeloperoxidase and its contributory role in inflammatory vascular disease.
Lau D; Baldus S
Pharmacol Ther; 2006 Jul; 111(1):16-26. PubMed ID: 16476484
[TBL] [Abstract][Full Text] [Related]
11. The free amino acid tyrosine enhances the chlorinating activity of human myeloperoxidase.
Vlasova II; Sokolov AV; Arnhold J
J Inorg Biochem; 2012 Jan; 106(1):76-83. PubMed ID: 22112843
[TBL] [Abstract][Full Text] [Related]
12. The other myeloperoxidase: Emerging functions.
Vanhamme L; Zouaoui Boudjeltia K; Van Antwerpen P; Delporte C
Arch Biochem Biophys; 2018 Jul; 649():1-14. PubMed ID: 29614255
[TBL] [Abstract][Full Text] [Related]
13. Intracellular localization of myeloperoxidase in murine peritoneal B-lymphocytes and macrophages.
de Araujo TH; Okada SS; Ghosn EE; Taniwaki NN; Rodrigues MR; de Almeida SR; Mortara RA; Russo M; Campa A; Albuquerque RC
Cell Immunol; 2013 Jan; 281(1):27-30. PubMed ID: 23434459
[TBL] [Abstract][Full Text] [Related]
14. PEGylated single-walled carbon nanotubes activate neutrophils to increase production of hypochlorous acid, the oxidant capable of degrading nanotubes.
Vlasova II; Vakhrusheva TV; Sokolov AV; Kostevich VA; Gusev AA; Gusev SA; Melnikova VI; Lobach AS
Toxicol Appl Pharmacol; 2012 Oct; 264(1):131-42. PubMed ID: 22884993
[TBL] [Abstract][Full Text] [Related]
15. Carbon monoxide-releasing molecule 3 inhibits myeloperoxidase (MPO) and protects against MPO-induced vascular endothelial cell activation/dysfunction.
Patterson EK; Fraser DD; Capretta A; Potter RF; Cepinskas G
Free Radic Biol Med; 2014 May; 70():167-73. PubMed ID: 24583458
[TBL] [Abstract][Full Text] [Related]
16. Growing significance of myeloperoxidase in non-infectious diseases.
Hoy A; Leininger-Muller B; Kutter D; Siest G; Visvikis S
Clin Chem Lab Med; 2002 Jan; 40(1):2-8. PubMed ID: 11916266
[TBL] [Abstract][Full Text] [Related]
17. Human myeloperoxidase in innate and acquired immunity.
Arnhold J; Flemmig J
Arch Biochem Biophys; 2010 Aug; 500(1):92-106. PubMed ID: 20399194
[TBL] [Abstract][Full Text] [Related]
18. Myeloperoxidase: a target for new drug development?
Malle E; Furtmüller PG; Sattler W; Obinger C
Br J Pharmacol; 2007 Nov; 152(6):838-54. PubMed ID: 17592500
[TBL] [Abstract][Full Text] [Related]
19. Reactions and reactivity of myeloperoxidase-derived oxidants: differential biological effects of hypochlorous and hypothiocyanous acids.
Pattison DI; Davies MJ; Hawkins CL
Free Radic Res; 2012 Aug; 46(8):975-95. PubMed ID: 22348603
[TBL] [Abstract][Full Text] [Related]
20. Hypochlorite-modified (lipo)proteins are present in rabbit lesions in response to dietary cholesterol.
Malle E; Wäg G; Thiery J; Sattler W; Gröne HJ
Biochem Biophys Res Commun; 2001 Dec; 289(4):894-900. PubMed ID: 11735131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
